Trial intelligence / Profile preview

Ciprofol Sedation ED50 in Elderly Knee Arthroplasty

NCT06293131Phase 1Completed

Sponsor
The Second Hospital of Shanxi Medical University
Start
May 2023
Primary completion
Sep 2023
Modality
Allosteric Modulators
Countries
1
01

Overview

Phase 1, open-label trial of ciprofol in Procedural sedation (PS), sponsored by The Second Hospital of Shanxi Medical University. Primary endpoints: Modified Alertness Sedation Score at 24 hours and Bispectral index at 24 hours. Started May 2023; status: completed.

02

Drugs

ciprofol
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT06293131.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06293131.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call